Cambridge Investment Research Advisors’s iShares iBonds Dec 2024 Term Treasury ETF IBTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-317,873
Closed -$7.63M 3620
2024
Q3
$7.63M Sell
317,873
-453,116
-59% -$10.8M 0.03% 605
2024
Q2
$18.5M Sell
770,989
-16,466
-2% -$394K 0.07% 277
2024
Q1
$18.9M Buy
787,455
+92,188
+13% +$2.2M 0.07% 267
2023
Q4
$16.6M Buy
695,267
+399,823
+135% +$9.53M 0.07% 273
2023
Q3
$7.04M Buy
295,444
+32,475
+12% +$773K 0.03% 503
2023
Q2
$6.26M Buy
262,969
+35,503
+16% +$848K 0.03% 557
2023
Q1
$5.46M Buy
227,466
+98,700
+77% +$2.36M 0.03% 589
2022
Q4
$3.07M Buy
128,766
+94,102
+271% +$2.25M 0.02% 848
2022
Q3
$830K Buy
+34,664
New +$841K ﹤0.01% 1602

Other funds holding IBTE

Cambridge Investment Research Advisors's IBTE Position: Q4 2024 in Review

Cambridge Investment Research Advisors sold out of iShares iBonds Dec 2024 Term Treasury ETF (IBTE) in Q4 2024, closing a stake of 317,873 shares — an estimated $7.63M sold.

Cambridge Investment Research Advisors first reported a position in IBTE in Q3 2022 and held it in 9 quarters. The position peaked at $18.9M in Q1 2024. 5 funds tracked by Wall St. Rank hold IBTE as of Q4 2024.

  • Cambridge Investment Research Advisors reported no remaining iShares iBonds Dec 2024 Term Treasury ETF position as of Q4 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 317,873 iShares iBonds Dec 2024 Term Treasury ETF shares in Q4 2024, an estimated $7.63M.
  • Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2024 Term Treasury ETF in Q3 2022 and held it in 9 quarters.
  • Cambridge Investment Research Advisors's iShares iBonds Dec 2024 Term Treasury ETF position peaked at $18.9M in Q1 2024.
  • 5 funds tracked by Wall St. Rank held iShares iBonds Dec 2024 Term Treasury ETF as of Q4 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.